The third national Japanese antimicrobial susceptibility pattern surveillance program: Bacterial isolates from complicated urinary tract infection patients.
Kobayashi K, Yamamoto S, Takahashi S, Ishikawa K, Yasuda M, Wada K, Hamasuna R, Hayami H, Minamitani S, Matsumoto T, Kiyota H, Tateda K, Sato J, Hanaki H, Masumori N, Hiyama Y, Yamada H, Egawa S, Kimura T, Nishiyama H, Miyazaki J, Matsumoto K, Homma Y, Kamei J, Fujimoto K, Torimoto K, Tanaka K, Togo Y, Uehara S, Matsubara A, Shoji K, Goto H, Komeda H, Ito T, Mori K, Mita K, Kato M, Fujimoto Y, Masue T, Inatomi H, Takahashi Y, Ishihara S, Nishimura K, Mitsumori K, Ito N, Kanamaru S, Yamada D, Hiroshi M, Yamashita M, Tsugawa M, Takenaka T, Takahashi K, Oka Y, Yasufuku T, Watanabe S, Chihara Y, Okumura K, Kawanishi H, Matsukawa M, Shigeta M, Koda S.
Kobayashi K, et al. Among authors: tanaka k.
J Infect Chemother. 2020 May;26(5):418-428. doi: 10.1016/j.jiac.2020.01.004. Epub 2020 Feb 17.
J Infect Chemother. 2020.
PMID: 32081647
Surveillance was undertaken with the cooperation of 41 medical institutions throughout Japan. Fluoroquinolone required a MIC(90) of 2-64 mg/L to inhibit the 325 Escherichia coli strains tested and the proportion of levofloxacin resistant E. coli strains increased to 38.5% …
Surveillance was undertaken with the cooperation of 41 medical institutions throughout Japan. Fluoroquinolone required a MIC(90) of 2-64 mg/ …